Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Venrock Healthcare Capital Partners
company
About
Venrock Healthcare Capital Partners is a fund dedicated to investing in publicly-held and privately-held healthcare companies.
- 11 - 50
Highlights
Details
- Industries
- Finance,Financial Services,Health Care,Venture Capital
- Founded date
- Jan 1, 1969
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Venture Capital
Venrock Healthcare Capital Partners is a fund dedicated to investing in publicly-held and privately-held healthcare companies. It leverages its venture expertise, rigorous data analysis, and long-term supportive orientation to support successful biotechnology companies within the public markets. The company is headquartered in Palo Alto, California with an office in New York, New York.
Investments
Number of Investments
Number of Lead Investments
4
2
Venrock Healthcare Capital Partners has made 4 investments. Their most recent investment was on
Dec 7, 2022, when Apogee Therapeutics raised $149M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 7, 2022
Apogee Therapeutics
|
Series B | $149M | Biotechnology | — |
|
Aug 12, 2022
Terns Pharmaceuticals
|
Post-IPO Equity | $65M | Biotechnology | Yes |
|
Jan 1, 2022
Apogee Therapeutics
|
Series A | $20M | Biotechnology | Yes |
|
Apr 25, 2018
Corvidia
|
Series B | $60M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
